Is Reviva Pharmaceuticals Holdings Inc. (RVPH) overvalued? · $7.6M cap
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
This page asks whether Reviva Pharmaceuticals Holdings Inc. (RVPH) looks expensive on cached numbers — not a short thesis.
No cached income statement for RVPH, so there is no earnings base to call rich or cheap.
RVPH currently screens at market cap $7.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next RVPH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the RVPH stock page for the full model, not this heading.
Not investment advice.